Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failure. - Tomelleri, Alessandro; Bond, Milena; Marvisi, Chiara; Campochiaro, Corrado; Farina, Nicola; Venerandi, Biancamaria; Matucci-Cerinic, Marco; Salvarani, Carlo; Dejaco, Christian; Dagna, Lorenzo (Rheumatology, 2025)